This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

Register by 26 June to save £1000

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
3-5 November 2026
RAIAmsterdam, Netherlands

Poul Sorensen
CEO at Inverna therapeutics
Speaker

Profile

Poul Sørensen has extensive leadership experience in R&D and corporate development from top tier international Biotech and Pharmaceutical companies across multiple indications within immuno-oncology, inflammation, neurology and immune disorders. Poul has more than 30 years’ experience and passion for translating ground-breaking innovation into therapeutics and new product developments, strategic co-operations and creation of new ventures and as a serial biotech entrepreneur Poul has co-founded several start-ups. Besides his role as CEO at Inverna he’s also currently Partner and Entrepreneur in Residence at Argobio Studio, a Paris based launch platform for Europe’s best medicinal science.

Poul holds a PhD in Biochemistry from Copenhagen University and is Honorary Professor in Biomedicine at Aarhus University in Denmark.